<p dir="ltr">Kidney transplant rejection occurs when the recipient&rsquo;s immune system identifies the new kidney as foreign and mounts an immune response against it. Rejection can be hyperacute, acute, or chronic, with acute rejection being most common within the first few months post-transplant. Despite advances in immunosuppressive therapies, rejection remains a major cause of graft loss and reduced transplant success.</p>
<h3 dir="ltr"><strong>Epidemiology Segmentation</strong></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Total Incident Cases of Kidney Transplants</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Total Living Cases of Kidney Transplants</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Type-specific Cases of Kidney Transplant Rejection</p>
</li>
</ul>
<h3 dir="ltr"><a href="https://www.delveinsight.com/report-store/kidney-transplant-rejection-epidemiology-forecast"><strong>Kidney Transplant Rejection Epidemiology</strong></a></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">In 2023, DelveInsight estimated ~44K incident kidney transplant cases in the 7MM, with the U.S. accounting for ~27K.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">In the U.S., there were ~2K acute and ~8K chronic kidney transplant rejection cases reported.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">These numbers are expected to rise across all regions by 2034.</p>
</li>
</ul>
<h3 dir="ltr"><a href="https://www.delveinsight.com/report-store/kidney-transplant-rejection-market"><strong>Kidney Transplant Rejection Market</strong></a></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">In 2023, the total Kidney Transplant Rejection market size in the 7MM was ~USD 3.9 billion, with the U.S. accounting for ~USD 2.4 billion.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">The U.S. market is expected to grow further with the launch of emerging therapies.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">EU4 and the UK contributed ~USD 1.4 billion, representing ~36% of the total 7MM market.</p>
</li>
</ul>
<h3 dir="ltr"><strong>Kidney Transplant Rejection Market Drivers</strong></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Increasing rates of hypertension and late maternal age are contributing to a higher incidence of preeclampsia, driving demand for improved diagnostics and treatments.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Growing adoption of biomarker-based screening and predictive diagnostics is enhancing early detection, leading to better patient outcomes and increased market activity.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Government and global health initiatives emphasizing maternal and fetal health are supporting investment in preeclampsia research and product development.</p>
</li>
</ul>
<h3 dir="ltr"><strong>Kidney Transplant Rejection Market Barriers</strong></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Current therapies mainly focus on symptom management and delivery; lack of disease-modifying treatments restricts market growth.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">In many regions, limited awareness among patients and healthcare providers leads to late detection, reducing the effectiveness of interventions.</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">High clinical trial failure rates and regulatory hurdles for maternal health drugs can delay the approval and commercialization of innovative therapies.</p>
</li>
</ul>
<h3 dir="ltr"><strong>Kidney Transplant Rejection Key Players</strong></h3>
<ul>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Medeor Therapeutics</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Eledon Pharmaceuticals</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Sanofi</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">TRACT Therapeutics</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Sangamo Therapeutics</p>
</li>
<li dir="ltr" aria-level="1">
<p dir="ltr" role="presentation">Asahi Kasei (Veloxis Pharmaceuticals)</p>
</li>
</ul>
<p dir="ltr">And others.</p>

Kidney Transplant Rejection Market 

Kidney Transplant Rejection Market Infographic

Kidney Transplant Rejection Market

Kidney Transplant Rejection Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape